CVS contributing to US opioid crisis, Justice Department alleges
Portfolio Pulse from
CVS Health Corp is facing allegations from the US Department of Justice for violating the Controlled Substances Act and the False Claims Act. The lawsuit claims CVS filled opioid prescriptions without legitimate medical purposes.
December 19, 2024 | 1:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
CVS Health Corp is accused by the DOJ of violating the Controlled Substances Act and the False Claims Act by filling opioid prescriptions without legitimate medical purposes.
The DOJ's lawsuit against CVS for allegedly filling illegitimate opioid prescriptions could lead to significant legal and regulatory challenges. This may negatively impact CVS's stock price in the short term due to potential fines, legal costs, and reputational damage.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100